Literature DB >> 23583676

Attenuation of LDHA expression in cancer cells leads to redox-dependent alterations in cytoskeletal structure and cell migration.

Robert Arseneault1, Andrew Chien, Jordan T Newington, Tim Rappon, Richard Harris, Robert C Cumming.   

Abstract

Aerobic glycolysis, the preferential use of glycolysis even in the presence of oxygen to meet cellular metabolic demands, is a near universal feature of cancer. This unique type of metabolism is thought to protect cancer cells from damaging reactive oxygen species (ROS) produced in the mitochondria. Using the cancer cell line MDA-MB-435 it is shown that shRNA mediated knockdown of lactate dehydrogenase A (LDHA), a key mediator of aerobic glycolysis, results in elevated mitochondrial ROS production and a concomitant decrease in cell proliferation and motility. Redox-sensitive proteins affected by oxidative stress associated with LDHA knockdown were identified by Redox 2D-PAGE and mass spectrometry. In particular, tropomyosin (Tm) isoforms Tm4, Tm5NM1 and Tm5NM5, proteins involved in cell migration and cytoskeletal dynamics, exhibited changes in disulfide bonding and co-localized with peri-nuclear actin aggregates in LDHA knockdown cells. In contrast, treatment with the thiol-based antioxidant N-acetylcysteine promoted the relocalization of Tms to cortical actin microfilaments and partially rescued the migration defects associated with attenuated LDHA expression. These results suggest that aerobic glycolysis and reduced mitochondrial ROS production create an environment conducive to cytoskeletal remodeling; key events linked to the high cell motility associated with cancer.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Actin; Cell motility; Lactate dehydrogenase A; Redox regulation; Tropomyosin-3; Warburg effect

Mesh:

Substances:

Year:  2013        PMID: 23583676     DOI: 10.1016/j.canlet.2013.03.034

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  37 in total

Review 1.  Targeting Cancer Metabolism and Current Anti-Cancer Drugs.

Authors:  Witchuda Sukjoi; Jarunya Ngamkham; Paul V Attwood; Sarawut Jitrapakdee
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.

Authors:  Tino W Sanchez; Guangyu Zhang; Jitian Li; Liping Dai; Saied Mirshahidi; Nathan R Wall; Clayton Yates; Colwick Wilson; Susanne Montgomery; Jian-Ying Zhang; Carlos A Casiano
Journal:  Mol Cell Proteomics       Date:  2016-10-14       Impact factor: 5.911

3.  Bioenergetics underlying single-cell migration on aligned nanofiber scaffolds.

Authors:  Abinash Padhi; Alexander H Thomson; Justin B Perry; Grace N Davis; Ryan P McMillan; Sandra Loesgen; Elizabeth N Kaweesa; Rakesh Kapania; Amrinder S Nain; David A Brown
Journal:  Am J Physiol Cell Physiol       Date:  2019-12-25       Impact factor: 4.249

4.  HPV E6/p53 mediated down-regulation of miR-34a inhibits Warburg effect through targeting LDHA in cervical cancer.

Authors:  Rong Zhang; Jing Su; Song-Lin Xue; Hui Yang; Li-Li Ju; Ying Ji; Kai-Hua Wu; Yan-Wei Zhang; Ye-Xin Zhang; Jian-Fang Hu; Min-Min Yu
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

Review 5.  Oxygen and metabolic reprogramming in the tumor microenvironment influences metastasis homing.

Authors:  Vinod S Bisht; Kuldeep Giri; Deepak Kumar; Kiran Ambatipudi
Journal:  Cancer Biol Ther       Date:  2021-10-25       Impact factor: 4.742

6.  The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer.

Authors:  Tian-Lin He; Yi-Jie Zhang; Hui Jiang; Xiao-Hui Li; Hai Zhu; Kai-Lian Zheng
Journal:  Med Oncol       Date:  2015-05-29       Impact factor: 3.064

7.  Glycerophosphoglycerol, Beta-alanine, and pantothenic Acid as metabolic companions of glycolytic activity and cell migration in breast cancer cell lines.

Authors:  Antje Hutschenreuther; Gerd Birkenmeier; Marina Bigl; Knut Krohn; Claudia Birkemeyer
Journal:  Metabolites       Date:  2013-11-27

8.  Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia.

Authors:  M Maftouh; A Avan; R Sciarrillo; C Granchi; L G Leon; R Rani; N Funel; K Smid; R Honeywell; U Boggi; F Minutolo; G J Peters; E Giovannetti
Journal:  Br J Cancer       Date:  2013-10-31       Impact factor: 7.640

9.  c-MYC responds to glucose deprivation in a cell-type-dependent manner.

Authors:  S Wu; X Yin; X Fang; J Zheng; L Li; X Liu; L Chu
Journal:  Cell Death Discov       Date:  2015-11-23

10.  Suppression of lactate dehydrogenase A compromises tumor progression by downregulation of the Warburg effect in glioblastoma.

Authors:  Juan Li; Shuchai Zhu; Jing Tong; Hui Hao; Jie Yang; Zhikun Liu; Yuxiang Wang
Journal:  Neuroreport       Date:  2016-01-20       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.